These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 2727781

  • 1. [Corinfar in ischemic heart disease associated with chronic obstructive bronchitis].
    Lazebnik LV, Shutemova EA, Krol AA.
    Sov Med; 1989; (2):51-4. PubMed ID: 2727781
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Use of ultrasonic inhalation of isoket in patients with ischemic heart disease associated with chronic obstructive bronchitis].
    Lazebnik LB, Tereshchenko SN, Gendel'man AM, Lesniak EA, Donina AS.
    Sov Med; 1991; (11):50-2. PubMed ID: 1767317
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Characteristics of external respiration function and pulmonary circulation in patients with ischemic heart disease complicated by disorders of intraventricular conduction].
    Orlov LL, Vorob'ev LP, Maev IV, Kausova EV, Shestakov VA, Filippova EV, V'iuchnova ES.
    Klin Med (Mosk); 1994; 72(5):25-7. PubMed ID: 7853809
    [Abstract] [Full Text] [Related]

  • 7. [Use of calcium antagonists under outpatient polyclinic conditions in patients with chronic obstructive bronchitis complicated by cor pulmonale].
    Butorov IV, Bodrug NI, Sandigurskiĭ MI.
    Probl Tuberk; 1988; (8):35-7. PubMed ID: 3143996
    [No Abstract] [Full Text] [Related]

  • 8. [Effects of corinfar, nitrosorbide and apressin on external respiration and blood flow in chronic obstructive bronchitis].
    Vorob'ev LP, Maev IV.
    Ross Med Zh; 1992; (1):40-1. PubMed ID: 1611269
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Mechanisms of the anti-anginal effect of korinfar].
    Voronkov LG, Sokolov NF.
    Farmakol Toksikol; 1988; 51(5):38-41. PubMed ID: 3208884
    [Abstract] [Full Text] [Related]

  • 14. [Effect of corinfar on hemodynamics in ischemic heart disease].
    Gol'dberg GA, Ermakova EN, Shakhshneĭder NM.
    Ter Arkh; 1986; 58(5):87-90. PubMed ID: 3526617
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Use of korinfar in the early stages of heart failure in ischemic heart disease].
    Goncharova LN, Danilova IV.
    Sov Med; 1987; (12):85-8. PubMed ID: 3445181
    [No Abstract] [Full Text] [Related]

  • 20. [Prospects for correcting the disrupted status of the cardiovascular system in acute myocardial ischemia by combined experimental use of phosphocreatine and corinfar].
    Kamilova UK, Kacharava VG, Vititnova MB, Saks VA, Kryzhanovskiĭ SA.
    Vopr Med Khim; 1991; 37(5):66-8. PubMed ID: 1759404
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.